Oxidized LDL activates blood platelets through CD36/NOX2–mediated inhibition of the cGMP/protein kinase G signaling cascade

Abstract

Key Points• oxLDL binds platelet CD36 to stimulate tyrosine kinaseand PKC-dependent activation of NOX2 and generation of ROS.• oxLDL-and hyperlipidemiainduced ROS mediate platelet desensitization to inhibitory cGMP signaling to facilitate platelet activation and thrombus formation.Oxidized low-density lipoprotein (oxLDL) promotes unregulated platelet activation in dyslipidemic disorders. Although oxLDL stimulates activatory signaling, it is unclear how these events drive accelerated thrombosis. Here, we describe a mechanism for oxLDLmediated platelet hyperactivity that requires generation of reactive oxygen species (ROS). Under arterial flow, oxLDL triggered sustained generation of platelet intracellular ROS, which was blocked by CD36 inhibitors, mimicked by CD36-specific oxidized phospholipids, and ablated in CD36 2/2 murine platelets. oxLDL-induced ROS generation was blocked by the reduced NAD phosphate oxidase 2 (NOX2) inhibitor, gp91ds-tat, and absent in NOX2 2/2 mice. The synthesis of ROS by oxLDL/CD36 required Src-family kinases and protein kinase C (PKC)-dependent phosphorylation and activation of NOX2. In functional assays, oxLDL abolished guanosine 39,59-cyclic monophosphate (cGMP)-mediated signaling and inhibited platelet aggregation and arrest under flow. This was prevented by either pharmacologic inhibition of NOX2 in human platelets or genetic ablation of NOX2 in murine platelets. Platelets from hyperlipidemic mice were also found to have a diminished sensitivity to cGMP when tested ex vivo, a phenotype that was corrected by infusion of gp91ds-tat into the mice. This study demonstrates that oxLDL and hyperlipidemia stimulate the generation of NOX2-derived ROS through a CD36-PKC pathway and may promote platelet hyperactivity through modulation of cGMP signaling. (Blood. 2015;125(17):2693-2703

The role of CD36 receptor in the pathogenesis of atherosclerosis

“…52 Erythrocytes CD36 receptor activates erythrocytes infected with plasmodium malaria. 1 CD36 receptor was identified as a receptor for the sequence of plasmodium malaria infected erythrocytes which affects the adhesion of infected blood cells to the endothelium of vessels in various organs such as heart, lung, liver and brain.…”

Enhanced Megakaryopoiesis and Platelet Activity in Hypercholesterolemic, B6-Ldlr −/− , Cdkn2a -Deficient Mice

“…40, 41 We observed increased markers of PLT activation by multiple measures in WTD-fed Cdkn2a -deficient strains compared to chow-fed mice. Whereas chow-fed B6- Ldlr −/− .MOLFch4subD mice exhibited elevated markers of PLT activation (Figure 3), both strains fed WTD exhibited significantly elevated PLT surface P-selectin and JON/A, following PAR4 stimulation (Figure 4).…”

Cyclic nucleotide‐dependent inhibitory signaling interweaves with activating pathways to determine platelet responses

“…Platelet activation by oxidized low‐density lipoproteins has been suggested to involve Src kinases, PKC, p47 phox phosphorylation, NADPH oxidase 2, and the production of reactive oxygen species ultimately leading to an inhibition of PKG 81. This mechanism might be similar to TSP1‐induced inhibition of PKA which has also been suggested to involve Src family kinases 82.…”